Treace Medical Concepts (TMCI) Amortization of Deferred Charges (2020 - 2026)

Treace Medical Concepts has reported Amortization of Deferred Charges for 7 years, with the latest figure at $262000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortization of Deferred Charges rose 254.05% year-over-year to $262000.0; the trailing twelve-month figure through Mar 2026 stood at $480000.0 (up 61.62% YoY), and the FY2025 full-year result was $292000.0, down 2.01% from the prior year.
• Amortization of Deferred Charges for Q1 2026 stood at $262000.0, up from $69000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $262000.0 in Q1 2026, with the low at $45000.0 in Q1 2022.
• Historically, Amortization of Deferred Charges has averaged $81941.2 across 5 years, with a median of $74000.0 in 2022.
• Annual changes were most pronounced in 2025 — Amortization of Deferred Charges declined 8.0% — and 2026, when it surged 254.05%.
• Treace Medical Concepts' Amortization of Deferred Charges stood at $75000.0 in 2022, then dropped by 1.33% to $74000.0 in 2023, then increased by 1.35% to $75000.0 in 2024, then slipped by 8.0% to $69000.0 in 2025, then soared by 279.71% to $262000.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at $262000.0 (Q1 2026), $69000.0 (Q4 2025), and $75000.0 (Q3 2025), per Business Quant data.